GNAQ and extranodal nasal NK/T cell lymphoma: Additionally, we established the SNT16 cell line with a CRISPR/Cas9-mediated GNAQ c.286A > T mutation, which simultaneously expressed equal levels of wild–type and mutant GNAQ (Figure S1), as all GNAQ mutation–positive NKTCL cases are heterozygous for this mutation.